<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02073669</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-13-0668-DS-CTIL</org_study_id>
    <nct_id>NCT02073669</nct_id>
  </id_info>
  <brief_title>Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults</brief_title>
  <official_title>Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv Lung Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of study is to evaluate the prevalence of latent TB in second generation immigrants
      from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the
      control native Israelis without a family member who was born in a country with high incidence
      of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the investigators
      expect that the second generation immigrants group will have more positive IGRA test than the
      control native group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2014</start_date>
  <completion_date type="Actual">November 2018</completion_date>
  <primary_completion_date type="Actual">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interferon gamma release assay ( IGRA)</measure>
    <time_frame>Up to 3 months after tuberculin skin test</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Latent Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Second generation immigrants from high TB incidence countries</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native Israelis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)</intervention_name>
    <arm_group_label>Native Israelis</arm_group_label>
    <arm_group_label>Second generation immigrants from high TB incidence countries</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-25

          -  Men and women

          -  Second generation immigrants from countries with high incidence of tuberculosis (above
             20 of 100,000).

          -  Native Israelis without a family member who was born in a country with high incidence
             of tuberculosis.

        Exclusion Criteria:

          -  Prior contact with a tuberculosis patient

          -  Working (more than a month) in high risk setting such as health care workers, working
             with immigrants from countries with high incidence of tuberculosis.

          -  HIV infection and any immunodeficiency condition.

          -  Recent live-virus vaccination

          -  Acute infectious disease

          -  Prior serious reaction to tuberculin skin test

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Israeli Defense Forces</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>February 25, 2014</study_first_submitted>
  <study_first_submitted_qc>February 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2014</study_first_posted>
  <last_update_submitted>January 24, 2019</last_update_submitted>
  <last_update_submitted_qc>January 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>latent tuberculosis</keyword>
  <keyword>tuberculin skin test</keyword>
  <keyword>Interferon gamma release assay</keyword>
  <keyword>immigration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Interferon-gamma</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

